| scholarly article | Q13442814 |
| P2093 | author name string | Jason R Buck | |
| H Charles Manning | |||
| Dewei Tang | |||
| Michael L Nickels | |||
| Yiu-Yin Cheung | |||
| P2860 | cites work | Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function | Q24296269 |
| An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 | Q24599479 | ||
| Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states | Q24631648 | ||
| Involvement of peripheral benzodiazepine receptor in the oxidative stress, death-signaling pathways, and renal injury induced by ischemia-reperfusion | Q28564914 | ||
| Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas | Q33655854 | ||
| Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy | Q33838502 | ||
| Inducible loss of one Apc allele in Lrig1-expressing progenitor cells results in multiple distal colonic tumors with features of familial adenomatous polyposis. | Q33840012 | ||
| Molecular imaging of gliomas with PET: opportunities and limitations | Q33961188 | ||
| SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair | Q34129717 | ||
| Role of peripheral benzodiazepine receptors in mitochondrial, cellular, and cardiac damage induced by oxidative stress and ischemia-reperfusion | Q34224014 | ||
| Rapid, Microwave-Assisted Organic Synthesis of Selective (V600E)BRAF Inhibitors for Preclinical Cancer Research | Q34488278 | ||
| Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline | Q34522608 | ||
| Imaging of a glioma using peripheral benzodiazepine receptor ligands | Q34594710 | ||
| Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging | Q34632108 | ||
| The peripheral benzodiazepine receptor: a promising therapeutic drug target | Q35181304 | ||
| Preclinical imaging evaluation of novel TSPO-PET ligand 2-(5,7-Diethyl-2-(4-(2-[(18)F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([ (18)F]VUIIS1008) in glioma | Q35213599 | ||
| Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide. | Q36081687 | ||
| Influence of TSPO genotype on 11C-PBR28 standardized uptake values | Q37087243 | ||
| The translocator protein | Q37865972 | ||
| Molecular imaging of the translocator protein (TSPO) in a pre-clinical model of breast cancer | Q39769015 | ||
| In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106. | Q40275502 | ||
| Targeted molecular imaging agents for cellular-scale bimodal imaging | Q40491443 | ||
| Binding characteristics of SSR180575, a potent and selective peripheral benzodiazepine ligand | Q40627579 | ||
| Involvement of the peripheral benzodiazepine receptor in the development of rheumatoid arthritis in Mrl/lpr mice | Q40701449 | ||
| Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas | Q42465912 | ||
| TNF-alpha induced PMN apoptosis in whole human blood: protective effect of SSR180575, a potent and selective peripheral benzodiazepine ligand | Q42973988 | ||
| Involvement of the peripheral benzodiazepine receptor in the development of cutaneous pathology in Mrl/Lpr mice | Q44264744 | ||
| Ligands of the peripheral benzodiazepine receptor have therapeutic effects in pneumopathies in vivo | Q44563789 | ||
| In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients | Q48151150 | ||
| Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients. | Q53084430 | ||
| In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa). | Q53267275 | ||
| Brain Tumors | Q60618613 | ||
| Targeted imaging of colonic tumors in smad3-/- mice discriminates cancer and inflammation | Q80140819 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4466-4471 | |
| P577 | publication date | 2014-08-08 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
| P1476 | title | Facile synthesis of SSR180575 and discovery of 7-chloro-N,N,5-trimethyl-4-oxo-3(6-[(18)F]fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, a potent pyridazinoindole ligand for PET imaging of TSPO in cancer | |
| P478 | volume | 24 |
| Q39181546 | Evaluation of TSPO PET Ligands [18F]VUIIS1009A and [18F]VUIIS1009B: Tracers for Cancer Imaging |
| Q41446521 | New structure-activity relationships of N-acetamide substituted pyrazolopyrimidines as pharmacological ligands of TSPO. |
| Q55456900 | Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18F]Fluoroethoxy)phenyl)-5-Methylpyrazolo[1,5-a]Pyrimidin-3-yl)-N,N-Diethylacetamide (18F-VUIIS1018A) to Image Glioma. |
| Q35827097 | Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study |
| Q38809524 | Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010 - 2015; part 2). |
| Q62862505 | [F]FEPPA: Improved Automated Radiosynthesis, Binding Affinity, and Preliminary in Vitro Evaluation in Colorectal Cancer |
Search more.